Rankings
▼
Calendar
NUVB Q3 2023 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena
NUVB
Nuvation Bio Inc.
$2B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$26M
Net Income
-$20M
EPS (Diluted)
$-0.09
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$631M
Total Liabilities
$19M
Stockholders' Equity
$612M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$26M
-$29M
+10.2%
Net Income
-$20M
-$27M
+27.8%
← FY 2023
All Quarters
Q4 2023 →